The third quarter earnings season is winding down, and only a handful of major companies have yet to report results. So far, the Q3 earnings season has been solid. As of Nov. 21, 95% of S&P 500 ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced ...
Eisai Completes Rolling Submission to US FDA for LEQEMBI (R) IQLIK (TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback